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Introduction
Ectodermal dysplasia (ED) is a clinically and genetically heterogeneous condition characterized by abnormal development of two or more of the following ectodermal-derived structures: hair, teeth, nails, and sweat glands Visinoni, et al., 2009] .
Anomalies in other organs and systems may also be observed [Pinheiro and Freire-Maia, 1994; Priolo, et al., 2000] . Anhidrotic or hypohidrotic ectodermal dysplasia (HED/EDA), the most common phenotype of ED, is characterized by a triad of signs comprising sparse hair (hypotrichosis), abnormal or missing teeth (anodontia or hypodontia) and inability to sweat (anhidrosis or hypohidrosis). Typical clinical manifestations also include dryness of the skin, eyes, airways and mucous membranes presumably due to the defective development of several exocrine glands. HED/EDA can be associated with dysmorphic features (forehead bumps, rings under the eyes, everted nose and prominent lips) and occasionally with absent nipples.
The most frequent form of HED/EDA (MIM305100) results from mutations in the EDA1 gene, located on chromosome Xq12-q13.1 and encoding ectodysplasin (MIM300451), a member of the Tumor Necrosis Factor (TNF) family Bayes, et al., 1998 ]. Mutations in the EDA receptor encoding gene EDAR, located on chromosome 2q11-q13 (MIM604095), or in the EDAR-Associated Death Domain encoding gene EDARADD, located on chromosome 1q42-q43 (MIM606603), have been shown to cause autosomal recessive and dominant HED forms respectively [Monreal, et al., 1999; Headon, et al., 2001; Bal, et al., 2007] . These three forms are clinically indistinguishable, probably because they alter a single signal transduction pathway.
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On the other hand, loss-of-function and missense mutations in the WNT10A gene (chromosome 2q35, MIM257980) have been shown to cause odonto-onycho-dermal dysplasia, a rare form of ectodermal dysplasia [Adaimy, et al., 2007; Nawaz, et al., 2009] . Subsequently, WNT10A mutations have been reported in various forms of ectodermal dysplasia, including in three patients with sweating anomalies Nagy, et al., 2010; van Geel, et al., 2010] .
In order to evaluate the impact of EDA1, EDAR, EDARADD and WNT10A mutations in HED/EDA, we have sequenced all four genes in a large cohort of 65 unrelated patients. Among them, 61 patients had HED/EDA. Our study shows that only four genes account for more than 90 % of cases in HED/EDA.
Patients and Methods

Patients
Since 2002, a total of 65 patients were recruited by the departments of Dermatology and Genetics of Necker-Enfants Malades Hospital. Patients included in this study presented abnormalities of at least two of the three following ectodermal structures: teeth, hair and sweat glands. Most of those patients (53/65) presented the classical triad of HED/EDA phenotype. The relatives of the probands occasionally presented abnormalities of only one epidermal structure. The great majority of cases were familial cases (48/65) of Caucasian origin (45/65). A total of 9/65 patients were born to related parents. Informed consent for DNA analysis and reproduction of the photographs was obtained from all individuals concerned.
Mutation detection
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Deleted: (Mikkola, et al., 1999; Laurikkala, et al., 2002; Mustonen, et al., 2004; Mou, et al., 2006; Schmidt-Ullrich, et al., 2006; Pummila, et al., 2007) Deleted: (Adaimy, et al., 2007; Nawaz, et al., 2009) Deleted: Nagy, et al., 2010; van Geel, et al., 2010) 21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   F  o  r  P  e  e  r  R  e  v  i  e  w   5 DNA was extracted from patients' blood leukocytes using the Illustra DNA extraction kit BACC3 (GE Healthcare), following manufacturer's instructions. All exons and at least 60 base pair of flanking intronic sequences of the EDA1 (NM_001399.4), EDAR (NM_022336.3), EDARADD (NM_080738.3) and WNT10A genes (NM_025216.2) were amplified by PCR using specific primers (see Supp. Table S1 ). Both DNA strands were sequenced using the Big Dye Table   S1 ). PCR products were migrated using an ABI3130 sequencer (Applied Biosystems), and analyzed with GeneScan Analysis software version 3.7 (Applied Biosystems).
A genome-wide scan for one large family carrying no known mutation was undertaken with 382 pairs of fluorescent oligonucleotides of the Genscan Linkage Mapping set, version II (average spacing of 10 cM, Perkin-Elmer Cetus) under conditions recommended by the manufacturer. To refine the novel HED locus identified, additional microsatellites DNA markers from chromosome 14q region were studied. After amplification, PCR products were pooled with GeneScan 400D ROX size standard ladder (0.3 µl; Applied Biosystems), and analyzed on an ABI3130 sequencer.
Results
A total of 31 EDA1 mutations, including 20 novel mutations were identified in 35/65 cases of our cohort (Table 1, Figure 1A , Supp. Figure S1A ). Most of those mutations were missense mutations (24/31), located in exons 3 and 5 to 9. The male patients carrying EDA1 mutations were severely affected, as they all displayed anomalies in the three ectodermal structures. Carrier females were occasionally moderately affected, but two displayed unusually severe symptoms (patients EDA1-F19 and EDA1-F24, Figure 1B1 -2).
As to the EDAR gene, a total of 10 mutations, including 5 novel mutations, were identified in 10/65 patients (Table 1, Figure 1A , Supp. Figure S1B ). Five mutations were dominantly, and five recessively inherited. They were mostly located in exons 9 to 12 (7/10).
Interestingly, the dominant mutations were all located close to the EDAR Death Domain (DD, two missense mutations, one single residue duplication and two frameshift mutations).
Clinical features of these patients were indistinguishable from those observed in EDA1 patients.
However, individuals carrying dominant EDAR mutations were less severely affected than their recessive counterparts (Figure 1C and D) . This was particularly true with respect to sweating ( Figure   1E1 -2). This mutation located near the EDARADD Death Domain (Supp. Figure S1C ), probably altered its interaction with EDAR and/or multimerization of EDARADD.
As to the WNT10A gene, a total of 8 mutations were identified in 14/65 cases (9 familial and 5 sporadic cases; Table 2, Figure 2 , and Supp. Figure S1D ). They included 5 novel missense mutations and the first WNT10A duplication identified to date. The p.F228I mutation was prevalent in our cohort (10/14 patients) and found in homozygote or compound heterozygote patients. None of those mutations were found in 150 control chromosomes from healthy Caucasian individuals. QMPSF analysis of the four exons of the WNT10A gene in six heterozygote patients failed to detect any intragenic deletion (not shown).
Interestingly, most patients carrying WNT10A mutations (10/14) presented with sweating anomalies, including total anhidrosis for two of them (WNT10A-F03 and S01). However, comparison of those patients with HED/EDA cases harboring mutations in the ectodysplasin pathway allowed us to identify slight differences in their respective phenotypes. Indeed, dermatological features (anomalies of hair and sweat glands) were less severe and none of the patients carrying WNT10A mutations presented facial dysmorphism. Their dental phenotype consisted in microdontia, while teeth agenesis was more frequent in patients carrying mutations in the ectodysplasin pathway (Table 2, Figure 1F1 -3 and 1G). The other four patients with WNT10A mutations presented with incomplete form of OODD or unclassified form of ED (Table   2 ).
Finally, among the 5/65 unexplained cases of our cohort, one patient was the proband of a fourgeneration French family, presenting an autosomal dominant HED (patient HED-F01, Supp. Table S2 ). Genome-wide scan analysis led to the mapping of this novel disease gene to a 5 cM interval on chromosome 14q12-q13.1 (Zmax = 4.8; Supp. Figure S3 ). The strongest candidate genes have been excluded by sequencing analysis (PAX9, NFKBIA, PSMA6, SNX6, MBIP). None of the remaining known genes mapping to this region were involved in either ectodysplasin or Wnt signalling pathways.
Discussion
Here we show that four genes (EDA1, EDAR, EDARADD and WNT10A) accounted for 92 % of cases in a series of 65 unrelated patients, of which 61 presented with HED/EDA. EDA1 mutations were prevalent (58 % of cases). WNT10A mutations were more frequent than EDAR mutations in our cohort, but both genes are each responsible for 16 % of HED/EDA cases ( Figure 1A ).. We also report here on a novel disease gene mapping to chromosome 14q12-q13.1 and accounting for autosomal dominant HED/EDA.
The phenotypes associated with EDA1, EDAR, and EDARADD mutations were indistinguishable and consistently included hypohidrosis or anhidrosis, sparse hair, and oligodontia with abnormal [Adaimy, et al., 2007; Bohring, et al., 2009] . We confirmed the involvement of WNT10A gene in OODD or OODD-like forms of ED (3/14 patients), and unclassified ED (1/14; Table 2 ). Moreover, 10/14 patients of our cohort harboring WNT10A mutations presented with anomalies corresponding to HED/EDA, ie hypohidrosis or anhidrosis associated with teeth and hair anomalies. Thus our results expanded the spectrum of WNT10A mutations to HED/EDA phenotype. The variability of phenotypes associated to WNT10A mutations is not understood yet. The type of mutations (nonsense or missense) and their functional effects could explain this broad spectrum of phenotypes.
Our study gives support to the high incidence of EDA1 mutations (35/61, 58 %), and the scarcity of EDAR mutations in HED/EDA (10/61, 16 %) [Vincent, et al., 2001; Chassaing, et al., 2006; van der Hout, et al., 2008] . Interestingly, while WNT10A was reportedly known to account for various forms of ED, we provide here the first evidence for its very high incidence in HED/EDA cases (10/61, 16 %) [Adaimy, et al., 2007; Bohring, et al., 2009; Nawaz, et al., 2009; Nagy, et al., 2010 ].
Yet, the mode of inheritance of WNT10A mutations remains unclear. While eight patients were homozygotes or compound heterozygotes, only one heterozygous mutation was identified in six patients. Although a single mutation could probably explain the moderate cases (WNT10A-F08, -F09 and -S04), the three severely affected patients may carry a second unidentified mutation (in intronic or regulatory sequences of WNT10A). Alternatively, a dominant mode of inheritance with variable penetrance could also explain the severe phenotype of these patients.
A higher proportion of tooth anomalies has been previously described in males harboring heterozygous WNT10A mutations . These sex-biased manifestations were not found in our cohort. Dental abnormalities were the most frequent manifestation in heterozygous patients in both sexes. This difference may result from the high frequency of the p.C107X mutation in the German/Turkish cohort ].
Most of the HED mutations reported here were missense mutations, located in functionally important domains of the protein (furin clivage site, collageneous and TNF domains for Ectodysplasin; Death Domain for EDAR and EDARADD). Interestingly, all dominant mutations reported to date in EDAR were located in its C-terminal region near its Death Domain. These mutations probably exert a dominant negative effect on the wild-type allele via the formation of non-functional multimers, unable to recruit EDARADD. All missense EDARADD mutations are located in (or very close to) the Death Domain of EDARADD, probably impairing its interaction with EDAR.
The involvement of the ectodysplasin/NF-κB and Wnt/β-catenin pathways in ectodermal appendage development has long been known Gat, et al., 1998 ]. Because the two pathways are involved in early steps of ectodermal placode development, one can hypothesize that the 10 % hitherto unknown mutations may lie in either of these two pathways.
In conclusion, WNT10A gene should be considered as a candidate gene for HED/EDA, especially in the clinical condition of microdontia, sweating anomalies, and absence of facial dysmorphism.
Alternatively, patients with the classical triad of HED/EDA signs and facial dysmorphism, should be first studied for EDA1 gene, except in non-X-linked familial cases. If no mutation is identified in EDA1, EDAR is the next gene to consider, before WNT10A and EDARADD.
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